Document is current
Any future updates will be listed below
-
Authors
Baune, Bernhard T.
Rosemann, Kevin
Hefter, Dimitri
Tonkul, Mustafa
Kavakbasi, Erhan
-
Funding
Funding for this research was provided by:
Universität Münster
- License Information
-
More Information
Article History
Received: 5 October 2025
Accepted: 10 March 2026
First Online: 17 March 2026
Declarations
:
: The study has been approved by the local institutional review board of the University Hospital Münster (2023-435-f-S) and has been conducted following ethical principles stated in the Declaration of Helsinki. Due to the regulations of the North Rhine-Westphalian health data protection law, written informed consent was not required to collect and analyze routine clinical data that clinicians could access as part of their clinical duties.
: Not applicable.
: EK received speaker and advisor honoraria from LivaNova and Janssen-Cilag. BTB received speaker/consultation fees from: AstraZeneca, Lundbeck, Pfizer, Takeda, Servier, Bristol Myers Squibb, Otsuka, LivaNova, Biogen, Angelini and Janssen-Cilag. Other authors have no conflict of interest.
